RRN11 Antibody

What is RRN11 and why is it significant in transcription research?

RRN11 encodes a 66-kDa protein that serves as an essential component of RNA polymerase I (Pol I) transcription machinery in the yeast Saccharomyces cerevisiae. Its significance lies in its role as part of the core factor (CF) complex necessary for transcription initiation by Pol I. The RRN11 protein specifically complexes with two other transcription factors, Rrn6 and Rrn7, forming a stable structure that also binds the TATA-binding protein. This complex is required for transcription by the core domain of the Pol I promoter, making it crucial for ribosomal DNA transcription .

What types of RRN11 antibodies are commonly used in research?

While commercial RRN11-specific antibodies are not widely documented in the provided search results, researchers working with RRN11 typically use either:

• Polyclonal antibodies - Offer broad epitope recognition but may have batch-to-batch variation

• Monoclonal antibodies - Provide consistent specificity to a single epitope

• Tagged-protein recognition systems - Many studies utilize epitope tagging (such as HA-tag or TAP-tag) of RRN11 followed by using commercial anti-tag antibodies

For instance, in chromatin immunoprecipitation studies, anti-HA tag antibodies (such as ab9110 from Abcam) have been used to detect HA-tagged Rrn11 in experimental systems .

What are the typical applications for RRN11 antibodies in transcription research?

RRN11 antibodies are primarily used in:

• Immunoprecipitation (IP) - To isolate RRN11-containing complexes from cellular extracts

• Chromatin Immunoprecipitation (ChIP) - To identify RRN11 binding sites on DNA

• Western blotting - To detect RRN11 protein expression levels

• Immunofluorescence - To visualize cellular localization of RRN11

In particular, ChIP assays utilizing tagged RRN11 have been instrumental in demonstrating the association of RRN11 with ribosomal DNA promoters, helping to establish its role in transcriptional regulation .

How should RRN11 antibodies be validated for specificity in experimental systems?

Proper validation of RRN11 antibodies should include multiple approaches:

• Western blot analysis - Verify a single band at the expected molecular weight (~66 kDa)

• Knockdown/knockout controls - Compare antibody signal in wild-type vs. RRN11-depleted samples

• Peptide competition assay - Pre-incubation with the immunizing peptide should abolish the signal

• Cross-reactivity testing - Verify lack of signal in species where the antibody should not react

• Immunoprecipitation followed by mass spectrometry - Confirm the identity of the precipitated protein

Following the examples set in antibody validation studies, researchers should document:

• Antibody dilution optimization (typically starting at 1:500-1:2000 for Western blots)

• Blocking conditions testing (BSA vs. non-fat milk)

• Alternative fixation methods if used for microscopy

What are the optimal conditions for immunoprecipitation of RRN11-containing complexes?

Based on protocols used for similar nuclear proteins:

• Cell lysis buffer composition:

  • 50 mM Tris-HCl, pH 7.5

  • 150 mM NaCl

  • 1% NP-40 or Triton X-100

  • 5 mM EDTA

  • Protease inhibitor cocktail

  • Phosphatase inhibitors (if phosphorylation is of interest)

• Immunoprecipitation protocol:

  • Pre-clear lysate with protein A/G beads (1 hour, 4°C)

  • Incubate with 2-5 μg antibody per 1 mg protein lysate (overnight, 4°C)

  • Add fresh protein A/G beads (2 hours, 4°C)

  • Wash 4-5 times with wash buffer (lysis buffer with reduced detergent)

  • Elute with SDS sample buffer or native elution buffer depending on downstream applications

For Co-IP experiments targeting the Rrn11-Rrn6-Rrn7 complex, gentler extraction conditions may be necessary to maintain complex integrity .

What controls are necessary when using RRN11 antibodies in ChIP experiments?

Proper ChIP controls should include:

• Input DNA - A sample of chromatin prior to immunoprecipitation (typically 5-10%)

• IgG control - Non-specific antibody of the same isotype and host species

• Positive control regions - Known binding sites (e.g., rDNA promoter regions)

• Negative control regions - Genomic regions not expected to bind RRN11 (e.g., silent genes)

• Biological replicates - At least three independent experiments

When analyzing ChIP data, enrichment should be calculated as percent input or relative to IgG control. For example, in studies examining Rrn11 binding to rDNA promoters, primers targeting the core promoter regions yielded significant enrichment compared to control regions .

How can RRN11 antibodies be used to study the dynamics of Pol I transcription initiation?

RRN11 antibodies can be employed in sophisticated experimental designs to elucidate the temporal and spatial dynamics of Pol I transcription initiation:

• ChIP-seq approach:

  • Perform chromatin immunoprecipitation with RRN11 antibodies followed by high-throughput sequencing

  • Compare binding profiles under different growth conditions or cell cycle stages

  • Analyze co-occupancy with other Pol I factors

• Live-cell imaging:

  • Generate fluorescently tagged RRN11 constructs

  • Validate function using complementation assays and antibody detection

  • Track recruitment to nucleolar regions during transcriptional activation

• Nascent transcriptome analysis:

  • Couple RRN11 immunoprecipitation with RNA-seq of associated transcripts

  • Identify actively transcribing regions associated with RRN11

These approaches have revealed that components of the core factor, including RRN11, are recruited to rDNA promoters in a sequential manner, with dynamics influenced by cellular growth conditions and metabolic state .

What experimental approaches can determine the phosphorylation status of RRN11 and its impact on complex formation?

Phosphorylation analysis of RRN11 can be performed using:

• Phospho-specific antibodies:

  • Develop antibodies against predicted phosphorylation sites

  • Validate with phosphatase treatment controls

• Phos-tag SDS-PAGE:

  • Run protein samples on Phos-tag gels to separate phosphorylated from non-phosphorylated forms

  • Detect with RRN11 antibodies

  • Compare wild-type with phospho-mutant variants

• Mass spectrometry-based phosphoproteomics:

  • Immunoprecipitate RRN11 using validated antibodies

  • Analyze by LC-MS/MS to identify phosphorylation sites

  • Quantify changes under different conditions

This approach has been valuable for related transcription factors, as demonstrated in studies of Rrn3p and RNA polymerase I, where distinct phosphorylation patterns correlated with functional states of the initiation complex .

How can protein-protein interaction networks of RRN11 be mapped using antibody-based methods?

Several antibody-dependent techniques can map RRN11 interaction networks:

• Sequential Co-IP (two-step IP):

  • First IP: Use RRN11 antibody to pull down complexes

  • Elution under native conditions

  • Second IP: Use antibodies against suspected interaction partners

  • Analyze by Western blot or mass spectrometry

• Proximity ligation assay (PLA):

  • Use primary antibodies against RRN11 and potential interaction partners

  • Apply secondary antibodies conjugated to oligonucleotides

  • Ligation and amplification generate fluorescent signals where proteins are in close proximity

• RIME (Rapid Immunoprecipitation Mass spectrometry of Endogenous proteins):

  • Crosslink protein complexes in vivo

  • Perform IP with RRN11 antibodies

  • Identify all associated proteins by mass spectrometry

These methods have confirmed the stable association of RRN11 with Rrn6 and Rrn7, as well as interaction with the TATA-binding protein, providing a comprehensive picture of the Pol I core factor architecture .

What are the most common reasons for failed RRN11 antibody experiments and how can they be addressed?

Additionally, for nucleus-localized proteins like RRN11, ensure sufficient nuclear extraction by including appropriate detergents and mechanical disruption methods in your protocol .

How can results from different RRN11 antibodies be reconciled when they yield conflicting data?

When faced with conflicting results from different RRN11 antibodies:

• Compare antibody characteristics:

  • Epitope locations - Different domains may be accessible in different contexts

  • Clonality - Polyclonal antibodies recognize multiple epitopes while monoclonals target a single epitope

  • Host species - Can affect background in certain applications

• Verify with alternative methods:

  • Use tagged RRN11 constructs and commercial tag antibodies

  • Perform RNA interference to confirm specificity

  • Use mass spectrometry to identify immunoprecipitated proteins

• Create a validation matrix:

  • Test each antibody in multiple applications

  • Document performance patterns

  • Consider creating a pooled antibody approach for improved detection

This systematic approach can help determine which antibody is most reliable for specific applications, as demonstrated in antibody validation studies for other nuclear proteins .

How can proximity labeling be combined with RRN11 antibodies to map the local protein environment?

Proximity labeling techniques can greatly enhance our understanding of the RRN11 interactome:

• BioID or TurboID approach:

  • Generate fusion proteins of RRN11 with biotin ligase

  • Validate expression and localization using RRN11 antibodies

  • After biotin incubation, perform streptavidin pulldown

  • Identify labeled proteins by mass spectrometry

• APEX2 proximity labeling:

  • Create RRN11-APEX2 fusion constructs

  • Confirm proper localization with RRN11 antibodies

  • Perform brief H₂O₂ treatment with biotin-phenol

  • Capture biotinylated proteins and identify by mass spectrometry

• Combined IP-proximity labeling:

  • Immunoprecipitate native RRN11 complexes with validated antibodies

  • Conjugate proximity labeling enzymes to the antibody

  • Perform labeling reaction on the isolated complexes

These approaches have the advantage of capturing transient interactions and providing spatial information about the RRN11 protein neighborhood within the nucleolus .

What computational approaches can enhance the design of high-specificity RRN11 antibodies?

Advanced computational tools can improve RRN11 antibody design:

• Epitope prediction and optimization:

  • Analyze RRN11 sequence for optimal epitope candidates:

    • High surface accessibility

    • High antigenicity

    • Low sequence similarity to other proteins

  • Screen for cross-reactivity against proteome databases

• Structure-based antibody design:

  • If RRN11 structure is available, employ structure-based design:

    • Target unique structural features

    • Predict antibody-antigen interactions

    • Optimize binding affinity and specificity

• Machine learning algorithms:

  • Use existing antibody-antigen interaction data to train models

  • Predict epitope-paratope pairs with highest specificity

  • Design optimal complementarity-determining regions (CDRs)

These computational approaches can significantly reduce the time and resources needed for antibody development while improving specificity, as demonstrated in recent antibody engineering studies .

How can single-cell approaches utilizing RRN11 antibodies provide insights into transcriptional heterogeneity?

Single-cell technologies can reveal cell-to-cell variation in RRN11 function:

• Single-cell CUT&Tag or CUT&RUN:

  • Use RRN11 antibodies to map binding sites in individual cells

  • Identify cell-specific binding patterns and correlate with transcriptional output

  • Uncover rare cell populations with distinct RRN11 genomic localization

• Mass cytometry (CyTOF):

  • Develop metal-conjugated RRN11 antibodies

  • Combine with antibodies against other transcription factors and phosphorylation markers

  • Characterize RRN11 complex states across heterogeneous cell populations

• Integrated multi-omics:

  • Combine antibody-based protein detection with transcriptomics

  • Correlate RRN11 protein levels with rRNA transcription at single-cell resolution

  • Map relationship between RRN11 complex formation and cellular metabolic state

These approaches can reveal previously undetected heterogeneity in RRN11 function across seemingly homogeneous cell populations, potentially uncovering new regulatory mechanisms in ribosomal DNA transcription .